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Abstract 
 
Transfer RNAs (tRNAs) depend upon proper tRNA editing and modification, as well as proper 
secondary and tertiary folding in order to be stable and correctly functional within the cell. One 
such tRNA modification is the methylation of guanine at its N-1 position to form N-1 
methylguanosine (m
1
G), found at position 9 (m
1
G9) in multiple cytoplasmic and mitochondrial 
tRNAs from Eukarya and Archaea. In the budding yeast, Saccharomyces cerevisiae, m
1
G9 is 
produced by the enzyme tRNA methyltransferase 10 (Trm10) on at least thirteen different tRNA 
substrates. Interestingly, multiple (up to three) different TRM10 homologs are encoded in 
metazoa (including humans), but the reason for the presence of these variants is currently 
unknown. However, the widespread conservation of Trm10, as well as the recent identification 
of disease-causing mutations in one human homolog (TRMT10A), suggests that this enzyme 
plays a crucial role in biology. Therefore, the overall goal of this project was to investigate the 
biological function of nine diverse Trm10 homologs. Deletion of TRM10  in S. cerevisiae does 
not cause obvious growth defects on normal media, but the trm10Δ strain is hypersensitive to the 
chemical 5-fluorouracil. Taking advantage of this hypersensitive phenotype, we identified three 
eukaryotic TRM10 homologs that could substitute for wild-type yeast Trm10, as measured by 
their ability to provide resistance to 5FU when expressed in S. cerevisiae. Among the six non-
complementing homologs, two are of significant interest because western blots revealed that they 
were abundantly expressed in yeast, suggesting that the lack of complementation is not due to 
defects in expression in S. cerevsisiae. Instead, for these two genes (one each from human and 
mouse), we hypothesize that the resulting enzymes do not methylate the same thirteen  tRNAs 
that are normally substrates for yeast Trm10, thus leading to the inability to complement the 
growth phenotype on 5FU. Preliminary primer extension data for the three eukaryotic TRM10 
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homologs that could substitute for the loss of wild-type Trm10 suggest that there are specific 
tRNA substrates within the cells that must modified in order to provide 5FU resistance.  
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Introduction 
 
In the study of biology, there exist universal mechanisms that have been conserved across all 
organisms, from bacteria to humans. One such mechanism is known as the central dogma of 
molecular biology; namely, that the genetic information contained within DNA gets transcribed 
by RNA polymerase into mRNA and then mRNA is subsequently translated by the ribosome into 
a growing polypeptide chain which folds into its native protein structure. Often over-looked in 
this process is the crucial role of tRNAs. In order for the tRNAs to be universally recognized by 
the ribosome, yet uniquely recognized by their cognate aminoacyl-tRNA synthetases with high 
specificity for correct amino acid charging, they must first be extensively processed. Many tRNA 
post-transcriptional processing events (and the enzymes that catalyze them) are conserved across 
all domains of life suggesting that the nucleotide modifications play a crucial role in biology 
(Swinehart, et. al. 2013). Typical tRNA processing steps include 5’ end maturation by RNase P 
cleavage, the three-nucleotide CCA addition to the 3’ ends, and additional nucleotide 
modifications introduced into the D-loops, T-loops, anticodon loops, and variable loops 
(Jackman and Alfonzo, 2013). While the precise reasoning behind nucleotide modifications of 
tRNAs is not fully understood, it is suggested that the modifications aid in correct folding of the 
secondary and tertiary structures of the tRNA as well as in some cases, enhancing the decoding 
of the mRNA (Helm, 2006). In S. cerevisiae, there are three known essential tRNA modifying 
enzymes: the Gcd10p-Gcd14p nuclear complex, the Tad2p-Tad3p cytosolic complex, and the 
cytosolic Thg1p which are responsible for m
1
A58, I34, and tRNA
His
G-1 respectively (Hinnebusch, 
et al., 1998; Keller W. and Gerber AP., 1999; Gu et al., 2003). While deletion of other single 
tRNA modifying enzymes do not cause phenotypic growth defects, pairwise deletion of more 
than one enzyme has been shown to result in lethal phenotypes, suggesting that the optimal 
5 | P a g e  
 
functionality of tRNAs in vivo is supported by a network of modifications or an overlap of 
functions. (Alexandrov et al., 2006; Chernyakov et al., 2008; Kotelawala et al., 2008; Phizicky 
and Alfonzo, 2010; Whipple et al., 2011). 
 
One important modification found in biology is the N-1 methylation of guanine, which has been 
found to occur at both positions 9 and 37. The m
1
G37 modifications that are found in all three 
domains of life are catalyzed by the proteins Trm5 (in Archaea and Eukarya) and TrmD (in 
Bacteria) and are crucial for yeast and bacterial growth (Christian and Hou, 2007). In contrast, 
m
1
G9 modification is only found in Eukarya and Archaea. In S. cerevisiae, the enzyme tRNA 
methyltransferase 10 (Trm10) catalyzes m
1
G9 on at least 13 different tRNA substrates by way of 
the S-adenosyl-methonine (SAM) cofactor, generating S-adenosyl-homocysteine (SAH) as the 
side-product (Figure 1). For tRNA modifying enzymes, tRNA substrate recognition is 
accomplished by a wide variety of mechanisms. For enzymes that modify only a single tRNA 
species, such as the tRNA
His
-specific guanylyltransferase (Thg1), the anticodon nucleotides act 
as a critical sequence element to be recognized by the enzyme (Jackman and Phizicky, 2006). 
However, for enzymes similar to Trm10 that act on more than one tRNA species, a challenge 
exists to recognize the correct tRNA substrates among the many species that exist at a given time 
within the cell. It is apparent that Trm10 activity requires tRNAs to have more than just a G 
residue at position 9, due to the observation that of the 19 tRNA species with G9 that have been 
investigated and whose modification sequences are fully known, approximately half are modified 
in vivo (Swinehart, et. al., 2013). Nonetheless, additional sequence elements in the tRNA that 
specify recognition are not known. It is therefore critical to understand the structural 
determinants for Trm10 recognition in order to completely understand its mechanism of action.  
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Trm10 is solely responsible for modification of all m
1
G9-containing tRNAs in vivo in S. 
cerevisiae, since the trm10Δ strain loses detectable m1G9 modification on all 13 tRNAs that are 
known to be modified (Swinehart, et. al. 2013). Despite this, the trm10Δ in S. cerevisiae is 
viable, although a phenotype of hypersensitivity to the presence of low concentrations of 5-
fluorouracil (5FU), which are otherwise not toxic to the TRM10 wild-type strain, was associated 
with the trm10Δ strain (Jackman et al., 2003; Alexandrov et al., 2006; Gustavsson and Ronne, 
2008).  In this case, we hypothesize that specific tRNA substrate(s) are defective when they lack 
m
1
G9 modification, thus causing the 5FU phenotype. It is known that some modifications to 
tRNAs are important for function and/or folding of the tRNA, and these effects could explain the 
role of Trm10 in 5FU hypersensitivity. 
 
In order to understand the role of Trm10 in this 5FU phenotype and its potential role in tRNA 
function/folding, we chose to use a genetic approach to examine the biological functions of 
Trm10 in S. cerevisiae (yTrm10), as well as its homologs found in Archaea and metazoan 
eukaryotes. In particular, we focused on investigating the roles of Trm10 enzymes from animals, 
which, unlike S. cerevisiae, encode more than one Trm10 gene. For example, in Homo sapiens, 
there are three homologs of yTrm10 known as: TRMT10A, TRMT10B, and TRMT10C. The 
importance of this enzyme for human biology is evident from a familial mutation of the human 
TRMT10A identified by us and another group that causes an absence of the TRMT10A mRNA 
and protein. This absence leads to glucose metabolic defects, short stature, and a smaller brain 
size in children (Igoillo-Esteve et al., 2013; Gillis et al., 2014). However, as with the 5FU 
hypersensitive phenotype in S. cerevisiae, the mechanism by which the presumed loss of m
1
G9 
modification causes the observed biological defects in humans is unknown.  
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Among the three human homologs of Trm10, TRMT10A is most similar to yTrm10 and 
TRMT10C functions in the mitochondria as part of an unusual protein-only version of the 5’-end 
tRNA maturation enzyme RNase P (Vilardo, et al. 2012). However, the function(s) and location 
of action for TRMT10B are unknown and methyltransferase activity of TRMT10C is apparently 
not strictly required for the ribonuclease activity of RNaseP, raising questions about the role of 
this enzyme in the complex (Vilardo, et al. 2012). The existence of the familial disease-
associated mutation in human TRMT10A described above provides further evidence for the 
distinct nature of the three Trm10 homologs in humans, since the presence of wild-type copies of 
TRMT10B and TRMT10C is apparently not able to substitute for the defect in TRMT10A in 
these patients.  
 
Besides in H. sapiens, Trm10 homologs have been identified in the mouse, Mus musculus (also 
encoding 3 homologs), the fruit fly, Drosophila melanogaster (2 homologs), the plant, 
Arabidosis thaliana (1 homolog), and many archaeal species, including Pyrococcus furiosus and 
Thermococcus kodakarensis, each of which encode one gene with similarity to TRM10. 
Therefore, an evolutionary argument can be made for the importance of this protein since it is 
highly conserved throughout eukaryotes and many archaea, which suggests that a significant 
selective pressure ensured its maintenance throughout the evolutionary timescale. It is for these 
reasons that the function of Trm10 enzymes is important to determine. Revealing the functions 
and activities of these homologs has been the primary focus of this project. We present the 
results of those studies here.  
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Part 1: Molecular Biology and Trm10 Functionality 
 
The S. cerevisiae Trm10 enzyme that produces m
1
G9 on at least 13 different tRNA species 
(Swinehart, et. al. 2013) is highly conserved in both Eukarya and Archaea (Figure 2). The 
phylogenetic analysis reveals a group of Trm10 homologs with sequences that are most similar 
to the yTrm10 (such as human TRMT10A). Our hypothesis is that these enzymes exhibit the 
same biological function as yTrm10 to methylate cytosolic tRNA(s). Other homologs cluster 
separately into groups that may also imply shared functions, but much less is known about the 
role of these enzymes. Several TRMT10C enzymes share sequence similarity, suggesting that 
they may share the function that has been associated with the human TRMT10C, which is to act 
in the mitochondria as part of the RNaseP complex along with a required cofactor SDR5C1 
(Vilardo et al., 2012). TRMT10B enzymes are found in many animals, but their biological 
function(s) have not been addressed in any system.  Besides the conservation of the Trm10 
protein, which is suggestive of a crucial catalytic role in biology, the human TRMT10A enzyme 
has been linked to disease in children (Figure 3) (Igoillo-Esteve et al., 2013; Gillis et al., 2014). 
Thus, understanding the function of these enzymes is important and here we have chosen to use 
S. cerevisiae as a model organism to analyze the function of Trm10 homologs from a wide 
variety of species. Specifically, my project seeks to answer the question on whether any of the 
Trm10 homologs exhibit the same biological function as yTrm10 and to analyze tRNA 
modification patterns in strains expressing various homologs to identify possible differences in 
tRNA substrates used by each enzyme. In order to tackle the first objective, the powerful tools of 
molecular biology have been enlisted.  
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The yTrm10 protein is non-essential for the cells, as evident by the cells’ survival on normal 
media when the gene is deleted. Yet, it has been found that this trm10Δ strain is hypersensitive to 
concentrations of 5FU (Figure 4) which do not normally inhibit the wild-type strain (Jackman et 
al., 2003; Alexandrov et al., 2006; Gustavsson and Ronne, 2008). This knowledge can be utilized 
for identifying if the Trm10 homologs function similarly to the yTrm10 when expressed within 
the trm10Δ yeast strain and grown on similar concentrations of 5FU; in other words, if the 
homolog can provide resistance to 5FU, it complements (makes up for) the loss of the wild-type 
TRM10. Here we investigate exactly which Trm10 homologs under study have functionality 
comparable to that of yTrm10 through the use of coloning, complementation assays and western 
blots. 
 
Results 
 
The Cloning Vector. Escherichia coli shuttle vectors were used for easier manipulation and 
have been engineered to include four key components: ampicillin resistance (ampR), self-
production of the amino acid leucine (LEU2 selection marker), a galactose promoter by which 
the TRM10 homolog can be induced, and a HA/FLAG epitope tagging of the Trm10 proteins for 
eventual western blot visualization. The galactose inducible (PGal) promoter was placed directly 
upstream of a multiple cloning site within the vector, allowing expression of the tested TRM10 
homolog by inclusion of galactose in the growth media. The specific primer design for the 
TRM10 homologs incorporated restriction sites that allowed both the DNA vector and TRM10 
homologs to be digested with the same REases and then ligated together by DNA Ligase (Figure 
5). Upon transformation of the ligated DNA into chemically competent E. coli XL-1 Blue cells, 
potential colonies were screened by restriction enzyme analysis and candidates were 
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subsequently verified by DNA sequencing. The fully verified clones included: S. cerevisiae 
Trm10 (as a positive control), Mus musculus TrmT10B and TrmT10C, Drosophila melanogaster 
TrmT10A, Homo sapiens TRMT10A, TRMT10B, and TRMT10C, Arabidopsis thaliana Trm10, 
Thermococcus kodakarensis Trm10, and Pyrococcus furiosus Trm10.  
 
Complementation Assay Analysis. The fundamental basis of yeast complementation assays is 
to conclude whether gene variants can substitute for the loss of the wild-type gene. With the use 
of two yeast strains (wildtype and trm10Δ) and the knowledge of the deletion strain’s 
hypersensitivity to 5FU, we were able to elucidate which Trm10 homologs could make-up for 
(complement) the loss of wild-type yTrm10 functionality. The verified clones listed above were 
transformed into the two yeast strains and subsequently grown on selective media (synthetically 
designed minimal media excluding leucine: SD-leu). The colonies which formed were then 
plated on a master SD-leu plate in patches for subsequent replica plating. The technique of 
replica plating is important for this experiment because it allows for the cells that originated from 
a single colony to be transferred onto numerous plates with varying media in order to 
qualitatively make distinguishes on their growth patterns. The various agar plates that were used, 
and in the order of replica plating, are as follows: SD-leu, SGal-leu, SGal-leu + 0.1μg/ml 5FU, 
SGal-leu + 1.0μg/ml 5FU, SGal-leu + 25μg/ml 5FU, and SD-leu. This particular ordering of 
plates is important for two reasons: the first being that the SD-leu plates were at the beginning 
and end where growth on both plates signifies that the transfer worked and that cells were not 
lost upon transfer; the second is that the SGal-leu plates prove that there is no observable 
phenotypic discrepancy between the two strains even though the wild-type strain’s Trm10 was 
induced for transcription by the addition of galactose within the media. In addition to the order of 
replica plating, the concentrations of 5FU that were used are crucial as well. The Ronne group 
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originally showed that a 5FU concentration of 1.0μg/ml was enough to inhibit the trm10Δ strain 
in growth (Gustavsson and Ronne, 2008).We also chose two other 5FU concentrations (0.1μg/ml 
and 25μg/ml) to allow us to detect a range of expected growth phenotypes. At the low end of 
0.1μg/ml, both TRM10 and trm10Δ strains are expected to grow well on media while at a high 
concentration of 25μg/ml both strains should be completely inhibited. From this technique of 
replica plating and the important incorporation of 5FU, were we able to identify three strains that 
complemented the loss of wild-type yTrm10, and six that failed to complement. Of the three 
strains, not including the successful positive control of reintroducing S. cerevisiae Trm10 into 
the deletion strain, D. melanogaster TrmT10A, H. sapiens TRMT10A, and A. thaliana Trm10 all 
showed growth comparable to that of the wild-type strain when grown on SGal-leu + 1.0μg/ml. 
The six strains that did not complement – M. musculus TrmT10B and TrmT10C, H. sapiens 
TRMT10B and TRMT10C, P. furiosus Trm10, and T. kodakarensis Trm10 – were all inhibited 
of growth on SGal-leu + 1.0μg/ml, similar to the vector control strain (Table 1).   
 
Western Blot – Visualizing Trm10 Expression. Western blot is a technique used to visualize 
proteins with the use of antibodies exclusive to the protein of interest. Specifically, a crude 
protein extract is run on a denaturing gel which separates the proteins based on size. After 
transferring the proteins to a nitrocellulose membrane, antibodies are used to specifically 
recognize a protein of interest, allowing visualization of the sizes and relative concentrations of 
the proteins under study. With the incorporation of the HA/FLAG epitopes engineered within our 
original cloning vector, we were able to test for Trm10 homolog expression in the strains, and 
used this information in conjunction with the complementation assay analysis to make 
predictions about conservation of function of the various homologs. We expected to see high 
levels of expression of a protein similar to the predicted size for the three Trm10 homologs 
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which complemented 5FU hypersensitive phenotype of the trm10Δ strain. For the cloned strains 
which failed to complement the trm10Δ strain, observing a protein band of expected size would 
suggest that the Trm10 homolog must have a function different than that of yTrm10 since its 
expression failed to provide resistance to 5FU. However, seeing no protein band could mean that 
the levels of Trm10 expression were weak or that the protein was unstable; either of these 
possibilities would predictably result in an inability of the homolog to complement the 5FU 
phenotype.  
 
First, we tested D. melanogaster TrmT10A, M. musculus TrmT10B, and the S. cerevisiae Trm10 
positive control strains in both SD-leu and SGal-leu media to ensure that the galactose inducible 
promoter (PGal) was effective in the up-regulation of TRM10 expression. These clones were 
transformed into the trm10Δ strain and grown on SD-leu media. The resultant colonies were 
transferred to SD-leu and SGal-leu broth and grown in bulk culture. After growth, the cell lysates 
were resolved by denaturing gels and probed for the presence of the epitope-tagged proteins. 
(Figure 6). In the western blots derived from yeast extracts, two prominent background bands 
were routinely observed but were relatively consistent across all samples, allowing us to 
distinguish the protein bands of interest from the background bands based on their expected sizes 
and differences in the samples grown under different conditions. In Figure 6, all samples grown 
in SD-leu only displayed the background signal, indicative that the Trm10 homolog was not 
expressed, as expected due to glucose-based repression of the PGal promoter. However, with the 
addition of galactose to the growth media (SGal-leu), we observed robust signals separate from 
the background, which suggests that they represent the Trm10 homolog and that TRM10 was 
successfully expressed by the PGal promoter. In each case, the bands are roughly consistent with 
the expected size of the expressed protein (based on the cloned gene sequence), although the M. 
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musculus TrmT10B protein band may migrate at a slightly higher apparent molecular weight 
than predicted. In this case, post-translational modifications (such as glycosylation) may explain 
the added size. Of these three strains, all showed considerable over-expression of the apparent 
Trm10 homolog in SGal-leu, including notably the M. musculus TrmT10B strain which did not 
complement the loss of wild-type TRM10.  
 
After validating the expected galactose-dependence of TRM10 expression, the remaining clones 
(M. musculus TrmT10C, H. sapiens TRMT10A, TRMT10B, and TRMT10C, A. thaliana Trm10, 
P. furiosus Trm10, and T. kodakarensis Trm10) were all transformed into the trm10Δ strain on 
SD-leu media and then grown in only SGal-leu broth culture for bulk growth. Following the 
same exact procedure as outlined above, extracts derived from these cells were all tested by 
western blot (Figure 7). The image again shows the consistent background bands across all 
samples, with several variable bands that were evident in individual lysates. From this western 
blot, we observed high intensity protein bands for both H. sapiens TRMT10A and A. thaliana 
Trm10, both of which are consistent with the observed complementation assay results that 
demonstrated each of these proteins are able to complement the lack of yTrm10. In addition, a 
high intensity band was seen for H. sapiens TRM10TB and a weaker band for T. kodakarensis 
Trm10, while no bands were observed for either H. sapiens TRMT10C or M. musculus 
TrmT10C. We believe that the potential smeared observed in the lane containing extracts from P. 
furiosus Trm10 is in fact bleed-over from the adjacent A. thaliana signal, and does not reflect 
actual P. furiosus Trm10 expression. As in Figure 6, there is general agreement between the 
migration of the bands and their expected molecular weights, with the possible exception of 
human TRMT10A, which is observed to migrate at a molecular weight that is slightly higher 
than what would be expected, and could again be due to post-translational modifications.  
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Discussion. Here we demonstrated that three eukaryotic Trm10 homologs (human and fruit fly 
TrmT10A and A. thaliana Trm10) are able to complement the 5FU hypersensitive phenotype of 
the yeast trm10Δ strain in a manner that is consistent with their robust expression in the 
engineered strains. Thus, we believe that these homologs share at least some common biological 
function(s) with yTrm10. In contrast, the two homologs (M. musculus TrmT10B and H. sapiens 
TRMT10B) are expressed well in S. cerevisiae but do not complement the trm10Δ phenotype, 
suggesting that they may have a different biological function when compared to yTrm10 or that 
they may potentially modify a subset of tRNA species that are different from those of yTrm10. 
The latter case is particularly interesting since human TRMT10B has been shown to catalyze in 
vitro m
1
G9 methyltransferase on at least one yeast tRNA substrate, but its overall substrate 
specificity is unknown (Vilardo et al., 2012). Therefore, a particular tRNA substrate (or 
substrates) may be critical in providing 5FU resistance, but modified differently by TrmT10B 
compared to the more closely related TrmT10A enzymes. This could explain the observed 
growth phenotype, as has been observed in several other cases, such as for the heat-sensitive 
phenotype from the loss of t
6
A that is complemented by the expression of tRNA
Lys
UUU but not 
other tRNA species that are targets of the t
6
A modification machinery (Crecy-Lagard, et. al., 
2015). S. cerevisiae Trm10 exhibits a selectivity toward certain tRNA substrates in vivo 
(Swinehart, et. al., 2013); if any of this subset of tRNA substrates are conserved in the 
complemented strains, but differently modified in the non-complementing strains, it is possible 
that those species are involved in providing 5FU resistance. Our results for the P. furiosus and T. 
kodakarensis Trm10 strains are less clear, but possibly interesting. The moderate-weak signal 
observed for T. kodakarensis Trm10 and its lack of complementation could simply mean that not 
enough Trm10 was present to rescue the 5FU phenotype. Another possibility, and one that 
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includes the lack of expression for P. furiosus Trm10, is that these proteins are not naturally 
found in S. cerevisiae and expressed at a temperature of 30°C; as thermophiles, their natural 
habitats are in much higher temperatures than that which was tested, with the result being 
potentially unstable protein product upon expression in S. cerevisiae. Alternatively, the 
possibility of alternative substrate specificity exhibited by T. kodakarensis Trm10 could also 
contribute to its inability to complement the phenotype. Addressing these possibilities could 
require either quantifying the amount of the Trm10 homolog protein that was expressed as 
compared to those homologs which were able to complement (purify the protein and conduct a 
Bradford assay or if antibodies are available conduct an ELISA assay) or identifying which 
substrates T. kodakaresnsis Trm10 acts on within the cells. Lastly, the lack of H. sapiens 
TRMT10C and M. musculus TrmT10C protein expression and complementation we observed in 
our assays can be readily explained by the requirement of the SDR5C1 cofactor for proper 
activity (Vilardo et. al., 2012) which was not co-expressed within our cloning vector because the 
essential nature of this cofactor for TrmT10C stability was not yet known at the time we began 
constructing the yeast strains; had the SDR5C1 cofactor been co-expressed, we would most 
likely have observed TrmT10C expression by western blot due to stability of TrmT10C . 
However, complementation of the loss of wild-type yTrm10 by the TrmT10C homologs, whose 
activities are within the mitochondria, remains questionable.  
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Part 2: Identifying Trm10 tRNA Substrates 
 
We identified three eukaryotic Trm10 homologs which can be expressed to high levels in S. 
cerevisiae and appear to function similarly to yTrm10 type yTrm10 based on their ability to 
complement the 5FU phenotype of the trm10Δ strain: D. melanogaster TrmT10A, A. thaliana 
Trm10, and H. sapiens TRMT10A. Based on this data, we hypothesize that they may catalyze 
similar methylation activities on a subset of tRNA species, and that this pattern of tRNA 
methylation is required for cells to be resistant to 5FU. Interestingly, however, although there is 
somewhat limited information about actual tRNA species that contain m
1
G9 modification in 
these organisms (D. melanogaster, A. thaliana, and H. sapiens), if this were to be valid, it 
suggests that those tRNA substrates are crucial to be modified within the cell as the modification 
has been conserved across an evolutionary timescale.  
 
Similarly, we have identified six Trm10 homologs which failed to complement the loss of wild-
type yTrm10, two of which (M. musculus TrmT10B and H. sapiens TRMT10B) were strongly 
expressed within the trm10Δ strain as detected by western blot; these two non-complementing 
enzymes therefore must be catalyzing different reactions within the cells and will ultimately 
require further study. Alternatively, they do catalyze the same reaction, but need a cofactor or 
need to be modified which may not happen in yeast. Interestingly, there is already evidence for 
distinct functions of the TRMT10A and TRMT10B homologs in humans. In the context of the 
human TRMT10A mutation that leads to the inherited disease syndrome, wild-type TRMT10B is 
still presumably functional in the affected individuals and therefore its presence is not sufficient 
to complement the process that are involved in human pathology. One potential activity of these 
two Trm10 homologs is that they are methylating a completely different set of tRNA substrates 
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within the trm10Δ strain and this set includes none of the normal targets of yTrm10 and its 
TRMT10A orthologs. The biochemical activities of TRMT10B enzymes have not been 
extensively determined in any system, although there is one report of methyltransferase activity 
of the human TRMT10B on a singly human cytosolic tRNA
Arg
, which is interestingly not one of 
the typical substrates of yeast Trm10 in vivo (Vilardo et al., 2012). Thus, it is possible that they 
are modifying a set of tRNA species that are different than those modified by the complementing 
enzymes listed above and therefore cannot provide resistance to 5FU. While there is no current 
data to support this hypothesis, another potential activity of the M. musculus TrmT10B and H. 
sapiens TRMT10B homologs is that they are simply not methylating tRNAs but rather are acting 
on different substrates within the cell, such as DNA or other RNA species. 
 
In order to test the first hypothesis for elucidating whether the complementing Trm10 enzymes 
and the non-complementing Trm10 enzymes are methylating different tRNAs, it is crucial to 
identify specific tRNA substrates for the homologs under study. One way to carry out this 
process is by the technique known as primer extension. After isolating low molecular weight 
RNA from cells grown in galactose media (expressing our Trm10 homologs), specific tRNA 
substrates are selected by the addition of a radioactively labeled DNA oligo nucleotide primer 
that is complementary in sequence to a specific area of the tRNA substrate of interest. The 
annealed primer is extended by Reverse Transcriptase (RT), creating a cDNA strand according to 
the primary sequence of the target tRNA. However, if the tRNA of interestwere to be modified 
with m
1
G9, in which methylation occurs on the Watson-Crick face of the template nucleotide, the 
RT cannot efficiently incorporate the incoming cytosine (C) nucleotide; the result is a cDNA 
fragment that is shorter in length than the full-length fragment resulting from primer extension of 
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an unmodified tRNA. This size difference is visualized on a gel with the radioactive phosphate 
acting as our source of detection.    
 
With this technique at our disposal, we decided to first test the complementing Trm10 enzymes 
(D. melanogaster TrmT10A, H. sapiens TRMT10A, and A. thaliana Trm10) on their ability to 
modify tRNA
Gly
GCC which is a known substrate for S. cerevisiae Trm10 in vivo (Figure 8) 
(Swinehart, et. al., 2013). Typically, using this assay yTrm10 is observed to modify m
1
G9 to the 
tRNA
Gly
GCC substrate with almost 100% efficiency. We sought to compare the levels of 
modification from our complementing Trm10 enzymes after isolating the RNA and carrying out 
primer extension (Figure 9). In the assay that was performed on RNA isolated from the 
complemented strains, m
1
G9 modification was seen only weakly, if at all, for both A. thaliana 
Trm10 and H. sapiens TRMT10A tRNA
Gly
GCC, while D. melanogaster TrmT10A had low, but 
slightly more detectable activity on tRNA
Gly
GCC when compared to the trm10Δ vector control. 
 
Discussion.
   
Based on this result, it is clear that m
1
G9 is not to full efficiency as seen most often 
in S. cerevisiae for tRNA
Gly
GCC in vivo. The first possible explanation for the primer extension 
results could be that because these Trm10 homologs were expressed in the trm10Δ strain while 
being grown on a rich, non-selective medium, the cells lost the selective pressure to maintain the 
plasmid. By losing this selection, it is conceivable that a portion of the cells within the culture 
slowly lost the plasmid as it was no longer beneficial for cell survival. This result would imply 
that there was less of the TRM10 homologs expressed and therefore less m
1
G9 modification.  
 
A second possible explanation for significantly lower levels of modification when compared to 
yTrm10 returns to the concept of a single tRNA in high abundance being able to rescue a 
phenotype observed with other tRNA modifying enzyme deficiencies, as seen previously (Crecy-
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Lagard, et. al., 2015). It is possible that for these complementing Trm10 homologs, even though 
preliminary data shows low methylation of tRNA
Gly
GCC, the “essential” tRNA that must be 
modified to restore cell viability is not tRNA
Gly
GCC. As stated previously, S. cerevisiae modifies 
9 tRNA substrates in vivo; by continuing primer extension and identifying the tRNA substrates 
of these complementing enzymes, determining the complete set of specific tRNAs that are 
modified by each complementing enzyme could help narrow the gap of possible targets in 
determining a single tRNA that could be responsible in restoring the 5FU phenotype.  
 
While these two possibilities could help explain the primer extension data, our results are still 
preliminary and will require further testing to validate what we have observed. What is clear, 
however, is that we have identified three Trm10 homologs whose function replaces that of wild-
type yTrm10 as measured by our previous yeast complementation assays. In addition, M. 
musuclus TrmT10B and H. sapiens TRMT10B have been characterized to have a biological role 
different than that of yTrm10 due to their inability to rescue the 5FU phenotype even under 
conditions where the proteins are in high abundance. Future work for this project will include 
repeating the current primer extension experiments, identifying tRNA substrates for the 
complementing Trm10 homologs, and characterizing the activity of M. musculus TrmT10B and 
H. sapiens TRMT10B to ascertain if they modify specific tRNA substrates or are potentially 
acting on a different substrate (DNA, RNA species) within the cells.  
 
 
 
 
 
20 | P a g e  
 
Materials and Methods 
 
Cloning Plasmid Preparation. Trm10 genes (S. cerevisiae TRM10, A. thaliana TRM10, D. 
melanogaster TRMT10A, H. sapiens TRMT10A, TRMT10B, and TRMT10C, M. musculus 
TRMT10B and TRMT10C, P. furiosus TRM10, and T. kodakarensis TRM10) were PCR amplified 
from cDNA constructs previously designed within the lab. These genes were cloned into both a 
2μ LEU2 vector downstream of the galactose promoter and N-terminal HA/FLAG epitope tag 
respectively. Clones were verified by single restriction enzyme digestion and DNA sequencing. 
Transformation of the clones was carried out in E. coli XL-1 Blue competent cells.  
 
Yeast Complementation Assay. Cloned plasmids were transformed into both trm10Δ and 
wildtype yeast strains following a standard protocol as described in (Abad et al., 2010) and 
grown on SD-leu media at 30°C. The resultant colonies were replica plated as described 
previously at 30°C.  
 
Western Blot. Cloned plasmids were transformed into both trm10Δ and wildtype yeast strains 
following a standard protocol as described in (Abad et al., 2010) and grown on SD-leu media at 
30°C. The resultant colonies were grown in 5ml SD-leu for overnight growth at 30°C. This was 
then used to inoculate 5ml SGal-leu at an OD 0.1. Cells were harvested at an OD 2.0. Lysis of 
the cells included 50μl lysis buffer (50μl of 1M Tris-Cl pH 7.5, 2μl of 500mM EDTA, 250μl of 
2% TritonX-100, 1μl of 1M DTT, 200μl of 5M NaCl, 2.5μl of 1000μg/ml pepstatin, 2.5μl of 
1000μg/ml leupeptin, and 10μl of 100mM PMSF) and the addition of zirconium beads. This 
mixture was vortexed at 4°C 10 times for 30sec each with a minute of ice bath between 
vortexing. After cell lysis, 10μl of SDS 2X loading dye + BME was added and the mixture 
boiled for 5 minutes at 100°C. The extracts were spun down and 10μl was loaded on a SDS-
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PAGE gel (12% resolving and stacking gel). The gel was run for approximately 1 hour at 180V 
and then transferred to a nitrocellulose membrane. Subsequent staining with Ponceau to ensure 
transfer of proteins was conducted. The membrane was blocked with 5% milk overnight. 
Exposure to the primary antibody (anti-FLAG) and then to the secondary antibody (anti-Rabbit 
conjugated with horseradish peroxidase) followed blocking with milk. The image was developed 
with X-ray film.  
 
Primer Extension. DNA oligo primer (Gly
GCC) was labeled with γ-32P ATP by heating 1μl of 
25μM primer, 2.5μl 10X PNK buffer, 2μl T4 PNK, 2μl γ-32P ATP, and 17.5μl ddH2O at 37°C for 
30 minutes and then subsequently at 72°C for 10 minutes. BioGelP6 spin columns were used to 
remove excess ATP. Labeled primers were annealed to tRNA
Gly
GCC (8μg/μl) by heating to 95°C 
and then cooling to room temperature (RT). Extension of the annealed DNA oligo primer was 
done with a final concentration of 0.4mM dNTPs; 2μl 5X Promega buffer, 0.8μl 5X dNTP, 0.6μl 
AMV-Reverse Transcriptase, and 1.6μl ddH2O were combined with annealing reaction and set to 
RT for 5 minutes, followed by 37°C for 1 hour. The reaction was combined with 10μL 2X 
loading dye and 5μL loaded onto a 10%PA/4M urea gel. The gel was run at 55W for 
approximately 2 hours, transferred to filter paper, exposed overnight, and imaged on a Typhoon 
Imager.  
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Figures 
 
 
 
Figure 1. Trm10 Mechanism of Action. tRNA substrates with G9 get methylated by Trm10 use 
of a SAM cofactor, producing m
1
G9 and SAH as the byproduct.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 | P a g e  
 
 
  
Figure 2. Phylogenetic Representation of TRM10 Homologs. Protein alignment of the Trm10 
homologs results in an observable phylogenetic trend. Trm10 homologs with similar structure to 
wild-type yTrm10 have been shown to complement the loss of wild-type yTrm10 in the trm10Δ 
strain. Several Trm10 homologs have been found to have mitochondrial activities and the 
localization and activity of a few other Trm10 homologs remains unknown. 
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Figure 3. Pleiotropic Disease Associated with Absence of Human TRMT10A. A familial 
mutation of H. sapiens TRMT10A resulted in children with microcephaly, short stature, and 
glucose metabolic defects. Figure adapted from Igoillo-Esteve, 2013.  
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Figure 4. 5FU Hypersensitivity. An absence of TRM10 in S. cerevisiae results in inhibition of 
cell viability when grown on media with 1μg/ml 5FU. Figure adapated from Ronne, 2008.  
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Figure 5. Cloning Procedure. The TRM10 gene was PCR amplified to include restriction 
enzyme sites similar to those within the original cloning vector. This vector includes the crucial 
Leu2 selection marker, gal promoter, and FLAG/HA epitope. After digestion with REases, the 
TRM10 genes were ligated into the digested vector.  
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Figures 6 and 7. Visualizing Trm10 Homolog Expression. (Figure 6): Western Blot of 3 
previously analyzed homologs (visualized by FLAG epitope within the plasmids), demonstrating 
the necessity of galactose within the media for expression of the gene. (Figure 7): Western Blot 
analysis of previously unstudied Trm10 homologs grown in the presence of galactose, visualized 
by speciﬁc epitopes (FLAG) that were engineered within the plasmids. 
 
 
 
Marker: 
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Figure 8. tRNA
Gly
GCC Example Primer Extension. Bold nucleotides in cloverleaf tRNA 
structure indicate primer binding for exenstion by reverse transcriptase. When visualized on a 
gel, m1G9 modiﬁcation can be visualized. Figures adapted from Jackman and Phizicky (2003) 
and Swinehart (2013). 
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Figure 9. Trm10 Homolog Primer Extension of tRNA
Gly
GCC. Visualization of m
1
G9 
modification for Trm10 homologs which complemented loss of wild-type yTrm10 and 
quantification of percent modification.  
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